It wasn't supposed to be this way: The 2017 tax cut and aggressive moves toward deregulation were supposed to pull the U.S. economy out of its glacial move higher.Economyread more
President Trump says Iran may not have intentionally downed an unmanned U.S. surveillance drone.Politicsread more
Health care companies claim they are not threatened by Amazon's potential foray into the space. A recent lawsuit in which CVS tried to prevent executive John Lavin from...Technologyread more
Slack pursued an unusual direct listing, meaning it did not have banks underwrite the offering.CNBC Disruptor 50read more
Slack's public market debut on Thursday will generate billions for venture firm Accel and healthy returns for Andreessen Horowitz and Social CapitalTechnologyread more
Oil jumped as much as 6% on Thursday after Iran shot down a U.S. military drone, prompting President Trump to blast Tehran on Twitter.Energy Commoditiesread more
The road to the Fed's policy pivot to lower interest rates began in early May, with a tweet from President Trump on trade.Market Insiderread more
CNBC analysis using Kensho found that Disney, Verizon and Home Depot were some of the best performing Dow stocks in declining-rate environments.Investingread more
If Facebook cut corners in something as basic as the branding of its nascent crypto efforts, this dispute could give ammunition to its many critics.Financeread more
Moore's entry into the 2020 race is worrisome for the GOP, which sees the race as its best chance to pick up a Senate seat next year.Politicsread more
Notorious "pharma bro" Martin Shkreli has reached a settlement with his former biopharmaceutical company Retrophin to resolve "all outstanding disputes" just week after he...Biotech and Pharmaceuticalsread more
Mercadolibre Inc.: "It may have bearish tendencies, but it's a bullish stock and it's one of the few from Latin America that I like. I think it's actually even better than eBay was. I think it's got better growth. I really like it and I have since 1999. "
Analog Devices, Inc.: "ADI made that transformational merger. I want them back on the show. Those guys are great guys."
Seattle Genetics, Inc.: "You know, Seattle Genetics is trading with all the biotechs and it shouldn't. It's got a lot of stuff in the pipeline, but let's accept the fact that the biotechs … right now are in some sort of bearish phase. These always end."
AbbVie Inc.: "AbbVie is just fabulous. I think it can still go higher even though it's been a monster."
Antero Midstream Partners: "I've got to tell you, Antero is a very, very good company."
Platform Specialty Products Corp.: "Don't like Platform Specialty. Why? Because I think that DowDuPont, which is being run by Ed Breen, is a much better company. That's the one I recommend in this sector, not Platform. "